The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

4 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Effect of prime-site sequence of retro-inverso-modified HTLV-1 protease inhibitor.EBI
Kyoto Prefectural University of Medicine
Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles.EBI
Kyoto Pharmaceutical University
Maintaining potent HTLV-I protease inhibition without the P3-cap moiety in small tetrapeptidic inhibitors.EBI
Kyoto Pharmaceutical University
Locking the two ends of tetrapeptidic HTLV-I protease inhibitors inside the enzyme.EBI
Kyoto Pharmaceutical University